Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Ellipses, Enlivex, Evgen, Insilico, Merck, Novocure, Novomedix, Oxford.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Codagenix, Crinetics, Endeavor, Harbour, Junshi, Karyopharm, Obseva, Osivax, Pharmazz.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Antios, Assembly, Astrazeneca, Bavarian Nordic, Citius, Teva.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aerie, Alnylam, Alvotech, Caladrius, Cingulate, Cytokinetics, Edesa, Eli Lilly, Ensysce, Luxa, Pfizer, Recardio, Springworks, Windtree.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Altamira, Astrazeneca, Bharat, Biohaven, Depymed, Eiger, Greenwich, Immunitybio, Immunogen, Nymox, Ocugen, Regeneron, Salubris, Sanofi, Therapeuticsmd.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Antares, Benevira, Biomx, Blade, CASI, Clearmind, Dongcheng, Galapagos, Genocea, Halozyme, Insilico, Imaginab, Journey, Kalivir, Knight, Padagis, Rigel, Roche, RS, Scipher, Scisparc, Synthonics, Sparrow, Tianshi, ZZ.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Alnylam, Antengene, Armata, Aurinia, Biond, Chinook, Compass, Concert, Day One, Hansa, Idorsia, Janssen, Liminal, Neurocrine, Pfizer, Polypid, Rapt, Regeneron, Salubris, Saniona, Seagen, Stealth, Tenax, Teva, UCB, Visen.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alcon, Aptamer, Cantargia, Catalyst, Elicio, Entasis, Immunocore, Immunome, Innoviva, Kala, Lupagen, Medison, Mirum, Pharmacyte, Pinotbio, Quoin, Satiogen, St. Jude, Umoja and Vertex.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aileron, Aldeyra, Argenx, Athersys, Avalo, Axsome, Belief, Bridgebio, Enanta, Foghorn, Healios, Insmed, IO Biotech, Lipidor, Menarini, Lysogene, Mustang, Ocuphire, Qlaris, Radius, Recce, Regencell, Rocket, Scilex, Tricida, Ultragenyx, Zealand.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbvie, Biontech, Eiger, Eli Lilly, Indaptus, Karyopharm, Merck, Mersana, Mirati, Novartis, Pfizer, Poxel, PTC, Saniona, Sanofi, Siga, Simcere, Tallac, Tetra, Umecrine, Valneva.